Can psilocybin be safely administered under medical supervision? A systematic review of adverse event reporting in clinical trials
Drug Science Policy and Law 2022 Jeremy Roscoe, Olivia Lozy 30 citations
This systematic review investigates whether clinical trials of psilocybin support criterion number three of the drug's schedule I designation: There is a lack of accepted safety for use of the drug or other substance under medical supervision. Data were collected by using the PubMed database and conducting a search on November 24, 2021, with the search term psilocybin and applying the clinical...